Philip Hamann

614 total citations
17 papers, 416 citations indexed

About

Philip Hamann is a scholar working on Rheumatology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Philip Hamann has authored 17 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 4 papers in Pathology and Forensic Medicine and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Philip Hamann's work include Rheumatoid Arthritis Research and Therapies (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Philip Hamann is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Philip Hamann collaborates with scholars based in United Kingdom, United States and Germany. Philip Hamann's co-authors include Neil McHugh, Robert G. Cooper, Hector Chinoy, Dana C. Matthews, Frederick R. Appelbaum, Irwin D. Bernstein, David J. King, Janet F. Eary, Lois M. Hinman and Oliver W. Press and has published in prestigious journals such as Scientific Reports, Lara D. Veeken and Autoimmunity Reviews.

In The Last Decade

Philip Hamann

15 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Hamann United Kingdom 9 194 93 91 82 76 17 416
Pouya N. Dayani United States 13 284 1.5× 64 0.7× 96 1.1× 36 0.4× 60 0.8× 17 753
Yunxian Mo China 14 111 0.6× 205 2.2× 141 1.5× 31 0.4× 41 0.5× 32 562
Johannes A. M. te Poele Netherlands 11 219 1.1× 61 0.7× 146 1.6× 24 0.3× 14 0.2× 17 454
Ly Tran Netherlands 8 181 0.9× 111 1.2× 47 0.5× 9 0.1× 99 1.3× 21 333
Peter Herhaus Germany 10 163 0.8× 355 3.8× 101 1.1× 59 0.7× 9 0.1× 27 573
Hiroyuki Yamaoka Japan 13 22 0.1× 146 1.6× 69 0.8× 79 1.0× 86 1.1× 37 471
James B. Hayden United States 10 44 0.2× 177 1.9× 76 0.8× 29 0.4× 117 1.5× 30 487
Ronny Kalash United States 13 139 0.7× 122 1.3× 103 1.1× 35 0.4× 11 0.1× 36 506
Junyan Qian China 12 33 0.2× 123 1.3× 126 1.4× 25 0.3× 90 1.2× 40 418
P. Reinecke Germany 10 36 0.2× 83 0.9× 139 1.5× 29 0.4× 48 0.6× 35 418

Countries citing papers authored by Philip Hamann

Since Specialization
Citations

This map shows the geographic impact of Philip Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Hamann more than expected).

Fields of papers citing papers by Philip Hamann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Hamann. The network helps show where Philip Hamann may publish in the future.

Co-authorship network of co-authors of Philip Hamann

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Hamann. A scholar is included among the top collaborators of Philip Hamann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Hamann. Philip Hamann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chan, Antoni, Johannes Knitza, Vincenzo Venerito, et al.. (2025). Five years of the Digital Rheumatology Network: insights and future directions. 1(3). 89–98.
3.
Hamann, Philip, Johannes Knitza, Sebastian Kühn, & Rachel Knevel. (2023). Recommendation to implementation of remote patient monitoring in rheumatology: lessons learned and barriers to take. RMD Open. 9(4). e003363–e003363. 5 indexed citations
4.
Hamann, Philip, et al.. (2020). Capturing remote disease activity – results of a 12-month clinical pilot of a smartphone app in NHS rheumatology clinics in Bristol. Lara D. Veeken. 59(8). 2158–2161. 4 indexed citations
5.
Hamann, Philip, et al.. (2019). Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA. Lara D. Veeken. 59(7). 1709–1714. 8 indexed citations
6.
Hamann, Philip, Gavin Shaddick, Kimme L Hyrich, et al.. (2018). Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis. Lara D. Veeken. 58(5). 831–835. 9 indexed citations
7.
Hamann, Philip, Benoît Roux, James A. Heward, et al.. (2017). Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis. Scientific Reports. 7(1). 8024–8024. 31 indexed citations
8.
Hamann, Philip & Neil McHugh. (2016). Autoimmune serology. Oxford University Press eBooks. 1 indexed citations
9.
Hamann, Philip, Richard Holland, Kimme L Hyrich, et al.. (2016). Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti–Tumor Necrosis Factor. Arthritis Care & Research. 69(6). 783–793. 29 indexed citations
10.
Dieker, Jürgen, Wolfgang Schlumberger, Neil McHugh, et al.. (2015). Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis. Molecular Immunology. 68(1). 20–24. 5 indexed citations
11.
Hamann, Philip, Robert G. Cooper, Neil McHugh, & Hector Chinoy. (2013). Statin-induced necrotizing myositis – A discrete autoimmune entity within the “statin-induced myopathy spectrum”. Autoimmunity Reviews. 12(12). 1177–1181. 69 indexed citations
12.
Hamrita, Bechr, Hela Ben Nasr, Philip Hamann, et al.. (2011). L’apport thérapeutique des approches protéomiques dans les cancers. Gynécologie Obstétrique & Fertilité. 39(2). 87–93. 1 indexed citations
13.
Hamann, Philip, et al.. (2010). Availability of and use of Intralipid (lipid rescue therapy, lipid emulsion) in England and Wales. Emergency Medicine Journal. 27(8). 590–592. 7 indexed citations
14.
Boghaert, Erwin R., Latha Sridharan, Kiran Khandke, et al.. (2008). The oncofetal protein, 5T4, is a suitable target for antibody-guided anti-cancer chemotherapy with calicheamicin. International Journal of Oncology. 32(1). 221–34. 28 indexed citations
15.
Boghaert, Erwin R., Kiran Khandke, Latha Sridharan, et al.. (2006). Tumoricidal effect of calicheamicin immuno-conjugates using a passive targeting strategy. International Journal of Oncology. 28(3). 675–84. 35 indexed citations
16.
Press, Oliver W., Janet F. Eary, Frederick R. Appelbaum, et al.. (1996). Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.. PubMed. 56(9). 2123–9. 171 indexed citations
17.
Konertz, Wolfgang, et al.. (1992). Aortic valve replacement with stentless xenografts.. PubMed. 1(2). 249–52. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026